Lee-Ann Wagner
Overview
Explore the profile of Lee-Ann Wagner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
67
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fink J, Maguire R, Blakeman T, Tomlinson L, Tomson C, Wagner L, et al.
Kidney Med
. 2022 Sep;
4(9):100527.
PMID: 36046613
Rationale & Objective: Some drugs prescribed for chronic kidney disease (CKD) may become hazardous on sick days with volume depletion by increasing the risk of acute kidney injury (AKI) and...
2.
Belkin M, Doerfler R, Wagner L, Zhan M, Fink J
Kidney360
. 2022 Apr;
2(4):629-638.
PMID: 35373040
Background: The comparative utility of performance-based functional assessments in predicting adverse outcomes in CKD is unknown. To examine their relative utility, we examined three performance-based functional assessments in an observational...
3.
Hall R, Blumenthal J, Doerfler R, Chen J, Diamantidis C, Jaar B, et al.
Am J Kidney Dis
. 2021 May;
78(6):837-845.e1.
PMID: 34029681
Rationale & Objective: Adults with chronic kidney disease (CKD) may be at increased risk of adverse effects from use of potentially inappropriate medications (PIMs). Our objective was to assess whether...
4.
Wagner L, Fink J
Clin J Am Soc Nephrol
. 2021 Mar;
16(4):499-501.
PMID: 33737322
No abstract available.
5.
Amirahmadi R, Childress J, Patel S, Wagner L
BMJ Case Rep
. 2021 Mar;
14(3).
PMID: 33674290
The cardiovascular effects of electronic cigarette use are unknown. Here we present a case describing a young, previously healthy patient without prior cardiopulmonary comorbidities who developed severe, acute cardiac dysfunction...
6.
Zhan M, Doerfler R, Xie D, Chen J, Chen H, Diamantidis C, et al.
Am J Kidney Dis
. 2020 Apr;
76(2):184-193.
PMID: 32317121
Rationale & Objective: Safe analgesic choices are limited in chronic kidney disease (CKD). We conducted a comparative analysis of harm from opioids versus nonsteroidal anti-inflammatory drugs (NSAIDs) in CKD. Study...
7.
Doerfler R, Diamantidis C, Wagner L, Scism B, Vaughn-Cooke M, Fink W, et al.
Clin J Am Soc Nephrol
. 2019 Mar;
14(4):583-585.
PMID: 30867156
No abstract available.
8.
Wagner L, Fink J
Semin Nephrol
. 2017 Apr;
37(2):194-208.
PMID: 28410653
Patients with chronic kidney disease (CKD) are at risk for complications both inherent to the disease and as a consequence of its treatment. The dangers that CKD patients face change...
9.
Offurum A, Wagner L, Gooden T
Expert Opin Drug Saf
. 2016 Sep;
15(12):1597-1607.
PMID: 27648959
Chronic kidney disease (CKD) confers a higher risk of adverse safety events as a result of many factors including medication dosing errors and use of nephrotoxic drugs, which can cause...
10.
Wagner L, Tata A, Fink J
Am J Kidney Dis
. 2015 May;
66(1):159-69.
PMID: 25987263
No abstract available.